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Object. Allergic fungal sinusitis (AFS) is a form of paranasal mycosis that often involves bone destruction and ex­
tension into the orbit and anterior skull base. Treatment consists of surgical extirpation and a course of corticosteroids. 
Despite frequent intracranial involvement, AFS is rarely reported in the neurosurgical literature.
Methods. The records of 21 patients with the histological diagnosis of AFS were reviewed. The histological diagno­
sis was based on findings of branching septated fungi interspersed with eosinophilic mucin and Charcot-Leyden crys­
tals without fungal invasion of soft tissue.
The average age of the 21 patients in this study was 25 years (range 9-46) and the male/female ratio was 3.75:1. All 
patients were immunocompetent. All had a history of chronic sinusitis and imaging findings of expansile disease in­
volving multiple sinuses. Fifteen patients had nasal polyposis, eight had erosion of bone, which was observed on com­
puterized tomography (CT) scans, eight had disease extending intracranially, and six had disease that involved the lam­
ina papyracea. All patients underwent transnasal and/or transmaxillary endoscopic approaches for debridement and 
irrigation, six underwent orbital decompression, and three underwent a bifrontal craniotomy for removal of intracranial 
extradural disease. No patient had a cerebrospinal fluid leak. Postoperatively, one patient was treated with amphotericin 
B and the other 20 were treated with a short course of corticosteroids. The follow-up period ranged from 2 to 19 years.
Conclusions. Allergic fungal sinusitis is a unique form of fungal disease that may mimic anterior skull base and 
paranasal sinus tumors. A cranial base team approach of neurosurgeons and otolaryngologists is recommended. Most 
cases can be successfully managed with transnasal and/or transmaxillary endoscopic techniques. A craniotomy is rare­
ly indicated unless there is the suspicion of dural invasion or extensive intracranial and/or intraorbital involvement that 
is inaccessible from below.
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Al l e r g ic  fungal sinusitis is a disease of the parana­sal sinuses that is most commonly managed by oto­laryngologists. Although there is still some debate regarding its exact pathogenesis, AFS is typically charac­
terized by an immune hypersensitivity reaction to fungal 
antigens that produces allergic mucin, which accumulates 
within the paranasal sinuses.30 Over time the mucin mass 
expands and can potentially erode through bone into the 
intracranial or intraorbital cavities, often mimicking ma­
lignant skull base tumors. Neurosurgeons usually encounter 
patients with AFS at this stage of the disease. if not di­
agnosed properly, AFS may be easily mistaken for malig­
nancy or invasive fungal disease, which could potentially 
lead to its overly aggressive treatment.24 Because AFS is a 
noninvasive disease, the allergic fungal mucin can be surgi­
cally removed while leaving the mucosal lining intact, obvi­
ating radical resection or potentially toxic antifungal thera­
py. We present our surgical experience of 21 patients with
Abbreviations used in this paper: AFS = allergic fungal sinusi­
tis; CSF = cerebrospinal fluid; CT = computerized tomography; 
EMRS = eosinophilic mucin rhinosinusitis; ig = immunoglobulin; 
MR = magnetic resonance.
AFS. The clinical presentation of the disease as well as 
its pathogenesis, neuroimaging features, histopathological 
characteristics, and surgical management are reviewed.
Clinical M aterial and Methods
Patient Population
A retrospective analysis was performed in 21 patients 
who underwent resection of pathologically verified AFS. 
The histological diagnosis was based on evidence of 
branching septated fungi interspersed with eosinophilic mu­
cin and Charcot-Leyden crystals without fungal invasion 
of soft tissue. Patient charts, operative reports, pathology 
reports, microbiological studies, and radiographs were re­
viewed. On neuroimaging studies, the lesions were classi­
fied as having paranasal sinus, intracranial, and/or intraor­
bital extension.
Surgical Management
The patients were treated by a multidisciplinary cranial 
base team composed of neurosurgeons and otolaryngolo­
gists. All patients underwent minimally invasive transnasal
J. Neurosurg. /  Volume 100 /  May, 2004 883
J. K. Liu, et al.
TABLE 1











1 30, M sinusitis, polyps, 
proptosis, diplopia
PNS, IC, IO no Aspergillus craniotomy/
endoscopic
2
2 33, F sinusitis, nasal obstruction, 
polyps, proptosis
PNS, IC, IO no Bipolaris craniotomy/
endoscopic
4
3 33, M sinusitis, nasal obstruction, 
polyps
PNS, IC, IO no Bipolaris craniotomy/
endoscopic
2
4 42, M sinusitis, nasal obstruction, 
polyps
PNS, IC no Bipolaris endoscopic 3
5 46, F sinusitis, nasal obstruction, 
polyps
PNS, IC no Bipolaris endoscopic 2
6 25, F sinusitis, nasal obstruction, 
polyps
PNS, IC no Bipolaris endoscopic 3
7 31, F sinusitis, polyps, 
nasopharyngeal mass
PNS, IC yes Dreschslera endoscopic 19
8 16, M sinusitis, proptosis PNS, IO no Dreschslera endoscopic 10
9 24, M sinusitis, polyps PNS no Dreschslera endoscopic 12
10 31, M sinusitis, polyps PNS no Exserohilum endoscopic 13
11 29, M sinusitis, polyps PNS no Alternaria endoscopic 11
12 32, F sinusitis, polyps PNS no Helminthsporium endoscopic 10
13 9, M sinusitis PNS no B polaris endoscopic 12
14 10, F sinusitis PNS no B polaris endoscopic 10
15 12, M sinusitis, polyps, proptosis PNS, IC, IO no B polaris endoscopic 13
16 16, M sinusitis, nasal obstruction, 
proptosis
PNS, IO no B polaris endoscopic 11
17 16, M sinusitis, polyps PNS no B polaris endoscopic 11
18 16, M sinusitis, polyps PNS no B polaris endoscopic 12
19 18, M sinusitis, polyps PNS no B polaris endoscopic 11
20 29, M sinusitis, polyps PNS no Curvularia endoscopic 11
21 30, M sinusitis PNS no Curvularia endoscopic 11
* Abx = antibiotics; PNS = paranasal sinus; IC = intracranial; IO = intraorbital.
endoscopic resections and some of them underwent direct 
transmaxillary (Caldwell-Luc) endoscopic resections. The 
transmaxillary approaches were performed through a sub­
labial maxillotomy. If indicated, a bifrontal transbasal ap­
proach was performed to remove intracranial and/or intra­
orbital disease. None of the patients underwent a traditional 
craniofacial resection (bifrontal craniotomy combined with 
a Weber-Fergusson transfacial approach). Among the pa­
tients in whom intracranial disease was removed, the anteri­
or skull base was reconstructed with a vascularized pericra­
nial flap and a fat and fascia lata graft. Temporary lumbar 
drainage was used in these cases.
Results
Clinical characteristics of the patients are listed in Table
1. The mean age of the patients at presentation was 25 years 
(range 9-46 years). There were l5 male and six female pa­
tients. The most common presentation of the disease was si­
nusitis (100% of patients), which was associated with nasal 
polyps (76% of patients), nasal obstruction (29% of pa­
tients), and/or proptosis (24% of patients). On neuroimag­
ing studies, all patients were found to have fungal disease in 
their paranasal sinuses (Figs. 1 and 2). In eight patients the 
disease extended intracranially and in six it extended intra- 
orbitally. All intracranial fungal diseases were entirely ex­
tradural without evidence of dural invasion.
All patients underwent endoscopic resection of fungal
debris, which was performed using a transnasal and/or a 
transmaxillary approach. Eighteen patients (86%) under­
went endoscopic treatment alone without the need for a cra­
niotomy. In five of these patients there was intracranial 
disease, which was adequately treated with an endoscopic 
resection. Three patients (14%) required an additional bi- 
frontal craniotomy to remove intracranial and intraorbital 
disease, which was inaccessible from below. Two of these 
patients, in whom the disease involved the superior or­
bit resulting in proptosis, underwent orbital decompression 
through the transcranial approach (Fig. 1). Cranial base re­
construction was performed in the three patients who under­
went a bifrontal craniotomy; this was accomplished using 
a fat and fascia lata graft supplemented by a vascularized 
pericranial flap. There were no postoperative CSF leaks.
All intraoperative fungal specimens were sent for micro­
biological analysis. The most common organism that was 
cultured was from the Bipolaris genus (57%) followed by 
those from the Dreschslera (14%) and Curvularia genera 
(10%). In all patients there was an elevated serum level of 
IgE. Only one patient received antifungal therapy. All pa­
tients remained free from disease after a mean follow-up 
period of 9 years (range 2-19 years).
Illustrative Cases
Case 1
This 30-year-old man presented with chronic sinusitis,
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Fig. 1. Case 1. Imaging studies obtained in a 30-year-old man who presented with sinusitis and right eye proptosis. Im­
ages reveal allergic fungal pansinusitis, which has eroded the anterior skull base and the right orbit, mimicking a sinonasal 
malignancy. The fungal debris was removed via a combined transnasal-transmaxillary endoscopic approach and a bifron- 
tal transbasal approach. A transcranial orbitotomy was performed to decompress the right orbit. Upper Left: Coronal CT 
scan. Upper Right: Axial CT scan. Lower Left: Coronal Tj-weighted MR image. Lower Right: Coronal Gd-enhanced 
Tj-weighted MR image.
headache, nasal congestion, and diplopia and proptosis of 
the right eye that had worsened during the previous 2 
months. On physical examination, the patient had obvious 
diplopia and proptosis of the right eye. His visual acuity and 
visual fields were intact. Motor and sensory examinations 
yielded normal findings. Computerized tomography and 
MR images revealed polypoid tissue in the nasal cavity and 
extensive fungal pansinusitis with bone erosion through the 
anterior skull base and the right orbit (Fig. 1).
The patient underwent an endoscope-assisted craniofa-
cial approach. First, a bifrontal transbasal craniotomy was 
performed to remove the intracranial portion of the mass. 
The fungal debris was entirely extradural; it was green and 
appeared cheeselike. The frontal sinuses were removed and 
cranialized, and the right orbital roof was decompressed to 
relieve the proptosis. From below, an endoscopic transnasal 
and bilateral transmaxillary (Caldwell-Luc) approach was 
used to remove nasal polyps and fungal material from all 
the paranasal sinuses. The sinuses were copiously irrigated 
and a pericranial flap was fashioned and sutured into the
J. Neurosurg. /  Volume 100 /  May, 2004 885
J. K. Liu, et al.
Fig. 2. Case 4. Coronal (left) and axial (right) CT scans obtained in a 42-year-old man who presented with sinusitis, 
polyps, and nasal obstruction. The images reveal AFS with extensive paranasal sinus involvement extending into the fron­
tal sinus and the adjacent epidural space. Fungal debris was removed entirely through a transnasal endoscopic approach.
base of the dura mater along the anterior skull base. There 
was no evidence of dural invasion or CSF leak. A lum­
bar drain placed at the time of operation was removed the 
next day.
The pathological specimen revealed AFS and microbio­
logical cultures displayed growth of Aspergillus species. 
The patient was discharged on postoperative Day 4 and was 
given a short course of systemic corticosteroids. He has not 
shown any evidence of disease recurrence at 2 years after 
surgery. This case was briefly described in another publica- 
tion.18
Case 4
This 42-year-old man presented with chronic sinusitis, 
nasal polyposis, and nasal obstruction. His neurological ex­
amination yielded normal findings. An endoscopic nasal 
examination revealed a greenish slime that raised suspi­
cions for fungal debris. A CT scan revealed an expansile 
mass in the paranasal sinuses with extension into the frontal 
sinuses and erosion of the anterior skull base (Fig. 2).
The patient underwent a transnasal endoscopic approach 
to remove the allergic fungal mucin. The fungal mass had 
eroded through the anterior skull base and created a large 
opening from the frontal sinuses into the nasal cavity. Be­
cause of this large opening, the fungal mass was entirely 
accessible from the transnasal endoscopic approach and a 
craniotomy was avoided. The lesion was also entirely extra­
dural and there was no evidence of a dural invasion or a 
CSF leak.
The pathological examination demonstrated AFS and 
microbiological cultures exhibited growth of Bipolaris spp. 
The patient was discharged on postoperative Day 1 and 
was given a short course of systemic corticosteroids. At the 
6-month follow up, an endoscopic nasal examination re­
vealed well-healed mucous membranes of the ethmoid and 
frontal sinuses. There was no evidence of recurrent fungal 
disease at the 3-year follow-up review.
Discussion
Allergic Aspergillus-induced sinusitis was first described
TABLE 2 





Invasion Host Immune Status
Role of 
Fungus Histopathological Findings
acute fulminant invasive 
fungal sinusitis
acute yes immunocompromised pathogen tissue necrosis, angioinvasion
chronic invasive 
fungal sinusitis




chronic yes immunocompetent pathogen chronic granulomatous tissue 
reaction, multinucleated giant 
cells
fungus ball (sinus mycetoma) chronic no immunocompetent saprophyte tangled mass of fungal hyphae
allergic fungal sinusitis chronic no immunocompetent,
atopic
allergen allergic mucin rich in eosinophils, 
Charcot-Leyden crystals
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in 1983 by Katzenstein and coworkers.12,13 They reported a 
series of immunocompetent patients who harbored a non- 
invasive fungal sinusitis that was histologically identical to 
allergic bronchopulmonary aspergillosis. The condition was 
initially thought to be an allergic reaction to Aspergillus 
spp., but since then other causative fungal species have been 
identified. Thus, the disease is now referred to as AFS.3
Fungal sinusitis is generally classified into one of five 
distinct clinical entities6,7,24,30 based on the host’s immune 
status and the presence or absence of tissue invasion (Table 
2). Two are found in patients whose immune systems are 
compromised: acute fulminant invasive fungal sinusitis, 
characterized by vascular invasion and tissue necrosis; and 
chronic invasive fungal sinusitis, characterized by tissue ne­
crosis and a low-grade inflammatory reaction. Three types 
of fungal sinusitis are found in immunocompetent patients: 
granulomatous invasive fungal sinusitis, characterized by a 
chronic granulomatous reaction with fungal invasion lim­
ited to the superficial mucosa; fungus ball (sinus myceto­
ma), characterized by a tangled mass of fungal hyphae with 
a minimal mucosal reaction; and AFS, characterized by 
a noninvasive immune hypersensitivity reaction to fungal 
elements. Allergic fungal sinusitis is the most recently de­
scribed and the most common form of fungal sinusitis. In 
our series, all patients were immunocompetent and there 
was no histological evidence of tissue invasion. It is imper­
ative to differentiate AFS from invasive forms of fungal 
sinusitis because allergic disease does not need to be treat­
ed with radical craniofacial surgery or potentially toxic anti-
fungal medications.11,24,36,38
Clinical Presentation
Allergic fungal sinusitis most commonly affects adoles­
cents and young adults.4,8,17,27 The mean age in our series 
was 25 years. Patients typically present with nasal ob­
struction and chronic allergic rhinosinusitis that has been 
refractory to medical management and to multiple sinus 
surgeries. They may also have a history of asthma, atopic 
disease, or nasal polyposis. In 90% of patients there are ele­
vated levels of an IgE specific to one or more fungal anti- 
gens.28 When the lesions become extensive, they occupy the 
entire paranasal sinuses and erode through the anterior skull 
base and lamina papyracea, mimicking malignant sinonasal 
tumors.20,34 Intracranial and orbital extension can produce 
headache, frontal lobe compression, facial deformity, diplo­
pia, proptosis, and/or visual loss.3,5,14,15,20,27,29,35,37 In the pres­
ent series, there were eight patients in whom the disease dis­
played intracranial extension and six in whom it displayed 
intraorbital extension (four of these patients had both intra­
cranial and intraorbital involvement). Proptosis was present 
in five (83%) of the six patients in whom there was intraor­
bital extension. Our patient population had a higher rate of 
intracranial and intraorbital extension of disease than previ­
ously reported. This may be due to patient referral patterns 
associated with our tertiary care medical centers.
Allergic fungal sinusitis should be suspected in any im­
munocompetent patient who has chronic sinusitis that is 
refractory to medical management. Young adults with a his­
tory of atopy and childhood asthma appear to be at a high­
er risk. Nasal polyps and a history of greenish brown con­
cretions produced by vigorous nose blowing are common. 
If proptosis is present, AFS should be considered in the dif-
Fig. 3. Chart showing the proposed pathogenesis for the perpet­
uation of AFS. Multiple factors are involved in this cyclic inflam­
matory cascade. Modified from Marple BF: Allergic fungal rhinosi­
nusitis: current theories and management strategies. Laryngoscope 
111 (6):1006-1019, 2001, with permission.
ferential diagnosis.3 The diagnostic criteria of AFS include 
Type I (IgE-mediated) hypersensitivity, nasal polyposis, 
characteristic neuroimaging findings, and histological da­
ta demonstrating characteristic allergic mucin with fungal 
forms but without tissue invasion.7,19,26
All patients in our series demonstrated histologically 
confirmed fungus and culture-positive AFS. There are some 
cases in which the histological findings are similar to AFS 
but lack evidence of fungal hyphae; in these cases the dis­
ease has been referred to as EMRS.8 There is some evidence 
that supports EMRS as a clinicopathological entity that is 
distinct from AFS. Patients with EMRS have a higher asso­
ciation with asthma, an increased incidence of aspirin sen­
sitivity, an increased incidence of IgG1 deficiency, and are 
generally older than patients with AFS. Although two pa­
tients in our series were older than 40 years of age, in both 
there was a positive fungal culture supporting the diagnosis 
of AFS.
Pathophysiology o f  AFS
Although the exact pathogenesis of AFS remains un­
known, it has been characterized as similar to the patho­
genesis of allergic bronchopulmonary aspergillosis.23,24,26 
It is postulated that ubiquitous fungi become deposited in 
the sinus and produce Type I (IgE)- and Type III (immune 
complex)-mediated reactions that trigger an intense eosin­
ophilic inflammatory response. The inflammation leads to 
sinus obstruction and subsequent stasis and inspissation of 
allergic mucin. This environment is ideal for proliferation of 
the fungus, which promotes further antigenic exposure and 
a host response, producing nasal obstruction and allergic 
mucin. This results in a vicious cycle of increased sinus mu­
cosal inflammation with drainage obstruction, reduced ven­
tilation, and further increased antigen contact (Fig. 3). As 
allergic fungal mucin accumulates within an involved para­
nasal sinus cavity, it begins to resemble and behave similar­
ly to a mucocele. As the “fungocele” expands with time, 
bone erosion can cause intracranial or intraorbital extension 
without tissue invasion.28
Initially, Aspergillus spp. was presumed to be the sus­
pected organism because of its morphologic similarities on 
histological examination.13 It is now known, however, that 
the Dematiaceae family of fungi, including the genera of 
Bipolaris, Curvularia, Exserohilum, Alternaria, Fusarium,
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Fig. 4. Photomicrographs of AFS tissue showing allergic mucin 
that contains abundant, dense, laminated clusters of degenerated eo­
sinophils (upper) and Charcot-Leyden crystals (center). Branch­
ing fungal hyphae are also observed (lower). H & E (upper and 
center) and Gomori methenamine-silver stain; original magnifica­
tions X 200.
Helminthosporium, and Drechslera, are more commonly 
associated with AFS.14,24,26,28 In our series of AFS, the Bipo- 
laris spp. were the predominat fungi cultured. In all but one 
patient (95%) there was a positive culture from the Demat- 
iaceae family. There was only one case of allergic aspergil­
lus sinusitis. Certain geographic locations have been impli­
cated in the incidence of AFS.9,11 The majority of reported 
cases of AFS have been in temperate regions with relative­
ly high humidity, such as the southeastern portion of the US 
and the Mississippi basin. The warm and moist climate in 
these regions may provide an optimal environment for fun­
gal proliferation.
Imaging Characteristics
The imaging findings of AFS are well recognized. Com­
puterized tomography scans commonly demonstrate ir­
regular hyperdense expansile masses involving multiple 
sinuses (Figs. 1 and 2).25,31 With the expansile nature of the 
accumulating allergic mucin, bone erosion through the an­
terior skull base and orbital walls can sometimes mimic ma­
lignant paranasal sinus tumors.14,32,34 Although the appear­
ance of this intracranial or intraorbital extension can be 
quite remarkable, there is usually no histological evidence 
of tissue invasion. The fungal elements can also act as a for­
eign body to induce precipitation of calcium salts, giving 
the lesion a heterogeneous appearance. On MR images, the 
high protein and low water concentrations of the allergic 
fungal mucin result in decreased intensities on T1- and T2- 
weighted images with peripheral enhancement in the sur­
rounding edematous paranasal sinus mucosa (Fig. 1).25 A 
signal void on T2-weighted MR images is highly suggestive 
of fungal debris and is helpful in differentiating a malignant 
neoplasm from fungal disease.
Histopathological Characteristics
On gross examination, the allergic fungal mucin is brown 
or dark green and often appears thick and caseous. Mi­
croscopically, the histological findings of AFS are identical 
to those in allergic bronchopulmonary aspergillosis. Fun­
gal hyphae are present within the allergic mucin and consist 
of degenerated inflammatory cells, lamellated aggregates 
of eosinophils, calcifications, and Charcot-Leyden crystals 
(Fig. 4). The hyphae, characterized by septae and acute an­
gle branching, are morphologically similar to Aspergillus 
spp. The fungal hyphae are poorly seen on hematoxylin and 
eosin preparations and require the application of Gomori 
methenamine-silver stains for adequate visualization. Un­
like the acute fulminant form of fungal sinusitis, there is no 
histological evidence of vascular or tissue invasion in cases 
of AFS.
Surgical Management
Successful treatment of AFS requires complete remov­
al of all fungal antigens and a course of systemic cortico­
steroids for long-term prevention of disease recurrence.28,30 
Complete extirpation of allergic mucin and fungal debris 
eliminates the antigen-inciting factor of the inflammatory 
response. Surgery also achieves adequate drainage and ven­
tilation of the sinuses. Inadequate sinus drainage allows 
further exposure to fungal antigens and an ongoing inflam­
matory response.34
888 J. Neurosurg. /  Volume 100 /  May, 2004
Allergic fungal sinusitis
It is important to remember that, although on neuro­
images AFS can exhibit dramatic bone erosion through 
adjacent anatomical spaces, it is not an invasive fungal dis­
ease. In the past, patients were unnecessarily treated with 
aggressive lateral rhinotomies, facial-degloving approach­
es, Weber-Fergusson transfacial approaches, and extensive 
mucosal exenteration. Because AFS is a noninvasive dis­
ease, the allergic fungal mucin occupying the sinus cavity 
can be removed in a blunt fashion while leaving the mu­
cosal lining intact. This can be achieved in most cases by 
performing minimally invasive endoscopic transnasal ap­
proaches. Maxillary sinus disease can be removed via an in­
tranasal antrostomy; however, in rare situations, a sublabi­
al transmaxillary approach (Caldwell-Luc procedure) may 
be needed to remove the allergic mucin in the maxillary si­
nus. The majority of the patients in this series (86%) were 
treated through endoscopic approaches alone, obviating the 
need for a craniotomy. A transnasal endoscopic approach 
alone was feasible in five of the eight patients in whom 
there was intracranial disease because the lesion was extra­
dural and remained in the midline field of endoscopic visu­
alization. Three of the six patients with intraorbital disease 
were treatable endoscopically because these lesions had 
eroded through the medial orbital wall and were accessible 
through the transnasal or transmaxillary routes.
If the intracranial and/or intraorbital extension of AFS are 
inaccessible from below, a bifrontal transbasal approach 
may be necessary to achieve total removal of fungal disease 
and to perform an orbital roof decompression. The three 
patients in this series who required a craniotomy in addition 
to an endoscopic approach all harbored intracranial disease 
that extended laterally across the anterior cranial fossa and 
intraorbital disease that occupied the superior orbit. These 
locations were inaccessible through endoscopic transna­
sal and/or transmaxillary approaches, thus necessitating a 
transcranial approach from above to remove fungal debris 
and decompress the orbital roofs.
Our strategy of surgical management allows successful 
debridement of allergic mucin and fungus without requiring 
disfiguring facial incisions or extensive facial osteotomies.18 
Because AFS is primarily a disease of the paranasal sinus­
es, most patients will initially present to an otolaryngolo­
gist. If AFS is diagnosed at an early stage before extensive 
intracranial and/or intraorbital involvement, the majority of 
patients can be surgically treated endoscopically. Only a 
few patients will require a craniotomy for complete fungal 
extirpation.
Adjuvant Medical Therapy
The concomitant use of systemic corticosteroid medica­
tions has been advocated as a means of suppressing the im­
munological reaction to the persisting fungal antigen as 
well as a means of controlling the underlying allergic rhini-
tis.6,10,23,24,26,28,29 The optimal dosing regimen and duration of
therapy have yet to be determined. Twenty patients in our 
series received a short course of corticosteroids postopera­
tively. There have been no cases of disease recurrence after 
a mean follow-up period of 9 years. The postoperative ad­
ministration of intranasal corticosteroids and nasal saline ir­
rigations may also be beneficial.6,26 Our patients have been 
followed up by their otolaryngologists for periodic exam­
inations and nasal irrigations.
Long-term systemic or local antifungal therapy can pro­
duce toxic and deleterious side effects and is not recom­
mended in the absence of histological evidence of tissue in- 
vasion.3,14,24 One patient (Case 7) in our series received a 
short course of intravenous amphotericin B without any 
systemic complications. This was the first patient in our 
surgical experience who was treated before we gained a bet­
ter knowledge of the disease. We now routinely treat 
patients with a short course of corticosteroids. The use of 
immunotherapy to downregulate the production of fungus- 
specif­
ic IgE and to decrease the inflammatory response appears 
promising.162122
Although some physicians have argued against the use 
of adjunctive antifungal therapy in patients with AFS,4,21,24 
there are some reports that support its use in severe cases of 
recurrent AFS after surgical debridement and corticosteroid 
therapy.1,2,16 Postoperative recurrences usually appear after 
the patient has been weaned from corticosteroid therapy. 
Topical or systemic antifungal medications may reduce the 
rate of recurrence by theoretically decreasing the fungal an­
tigen loads and, thereby, preventing subsequent hypersensi­
tivity reactions. The use of itraconazole has been reported 
to treat recurrent AFS successfully with minimal side ef- 
fects.1,33
Conclusions
Allergic fungal sinusitis is a unique form of fungal dis­
ease that may mimic anterior skull base and paranasal sinus 
tumors. Although AFS can appear “invasive” on neuroim­
ages, there is no histological evidence of tissue invasion. A 
cranial base team approach of neurosurgeons and otolaryn­
gologists is recommended. Most cases can be successfully 
managed with minimally invasive endoscopic techniques; a 
craniotomy may be indicated if there is extensive intracra­
nial involvement that is inaccessible from below.
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